The dual challenge of unbalanced inventory growth and medicine shortages
The dual challenge of unbalanced inventory growth and medicine shortages
In 2022 inventories grew at the major pharmaceutical companies while medicine shortages were widely reported. Why is supply and demand hard to balance in the pharmaceutical sector? (Pharma Boardroom, 14 June 2023)
Content Subscription
Would you like to receive more content like this, direct to your inbox? We publish white papers on a range of supply chain topics approximately once every one to two months. Subscribe below and we will notify you of new content. Unsubscribe at any time.